Genetika člověka
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Pipetovací špičky
Plasty pro buněčnou kultivaci
Systém pro dlouhodobé skladování vzorků
Zkumavky
Třepačky
Suché lázně
Centrifugy
End Point cyclery
Real-time PCR cyclery
Fluorometry
Spektrofotometry
Izolátory nukleových kyselin
Pipetovací roboty
Biobanking
Live Cell Imaging
Jednokanálové
Multikanálové
Sérologické pipety
Jednorázové pipety
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Biochemie
Imunoanalýza
GFP Stably Expressing Wehi-231 Cell Line
| Unit |
1×10⁶ cells / 1.0 ml |
|---|---|
| Cell Type |
Stable (KO/Expressing) Cells |
| Tissue Type |
Lymph |
| Organism |
Mouse (M. musculus) |
| Donor History | |
| Growth Properties |
Suspension ,lymphoblast |
| Growth Conditions |
PriCoat™ T25 Flasks (G299) are recommended for optimal cell culture. Dulbecco's Modified Eagle Medium (DMEM) ,High Glucose (TM500) + 10% FBS + 50 µM 2-Mercaptoethanol (CH045) + 1% Penicillin/Streptomycin Solution (G255) ,37.0°C ,5% CO₂. 0.1 µg/ml Puromycin (G264) for selection. Note: Selection drugs should be added to the culture medium after the first passage to ensure cells have recovered from freeze-thaw conditions. |
| Immortalization Method | |
| Full Information |
https://www.abmgood.com/GFP-Stably-Expressing-Wehi-231-Cell-Line-T3520.html |
This Wehi-231 cell lines stably expresses GFP. These cells are particularly useful for immunological and cancer research, especially in the context of B-cell lymphomas. GFP expression enables researchers to study cell behavior in real-time, including cell proliferation, apoptosis, and interactions with other cells and therapeutics. It’s valuable for live-cell imaging experiments that aim to understand the dynamics of tumor progression and response to treatment in lymphoma. The GFP Stably Expressing Wehi-231 Cell Line serves as a versatile tool for investigating B-cell biology and the efficacy of new drugs in preclinical models.
